广生堂 (300436)

Fujian Cosunter Pharmaceutical Co., Ltd.

ASZ

Tags

Loss-Making StocksGeneric DrugsInnovative DrugsPharmaceutical ManufacturingGene ConceptIncreasing Shareholder CountWest Coast of the Taiwan StraitHepatitis ConceptEquity TransferAssisted ReproductionHigh Price-to-Book RatioChiNext 300 IndexChiNext Small CapChiNext Healthcare

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 15926.70
  • Circulating A-Shares(W): 13671.98
  • Earnings Per Share(RMB): -0.7006
  • Net Assets Per Share(RMB): 2.4050
  • Operating Revenue(W RMB): 31583.81
  • Total Profit(W RMB): -10715.63
  • Net Profit Attributable to Parent(W RMB): -11158.44
  • Net Profit Growth Rate(%): -57.96
  • Weighted Return on Equity(%): -36.6600
  • Operating Cash Flow Per Share(RMB): -0.2830
  • Undistributed Profit Per Share(RMB): -3.5349
  • Capital Reserve Per Share(RMB): 4.6611

2. Main Business

The main business covers:

  • Providing scientific solutions for human liver health

3. Company Basic Information

  • Company Name: Fujian Cosunter Pharmaceutical Co., Ltd.
  • Listing Date: 2015-04-22
  • Industry: Pharmaceutical Manufacturing
  • Address: Building 16, Phase II Innovation Park, Haixi High-tech Industrial Park, No.7 Wulongjiang Middle Avenue, Fuzhou High-tech Zone, Minhou County, Fuzhou City, Fujian Province
  • Website: www.cosunter.com
  • Company Profile: The company was established by converting Guang Sheng Tang Co., Ltd. into a joint-stock company based on its audited net assets of RMB 44,427,973.90 as of July 31, 2011, at a ratio of 1:0.788, resulting in 35 million shares. The promoters contributed the net assets corresponding to their respective equity interests in Guang Sheng Tang Co., Ltd. This capital contribution was verified by Fujian Huaxing Certified Public Accountants Co., Ltd., which issued the Min Huaxing Suo (2011) Yan Zi H-011 “Capital Verification Report.” On September 30, 2011, the company completed the industrial and commercial change registration procedures at the Ningde City Administration for Industry and Commerce in Fujian Province, with the enterprise legal person registration number: 350926100003095 and registered capital of RMB 35 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Fujian Aohua Group Co., Ltd. Corporate Legal Person 2706.87 19.80
2 Fujian Pingtan Aotai Technology Investment Center (Limited Partnership) Corporate Legal Person 802.50 5.87
3 Zhangzhou Zhanxin Venture Capital Fund Management Co., Ltd. - Zhangzhou Yuanshan Great Health Industry Investment Fund Partnership (Limited Partnership) Asset Management Plan 800.00 5.85
4 Hong Kong Securities Clearing Company Ltd. Northbound Capital 174.63 1.28
5 China Europe Healthcare Hybrid Securities Investment Fund Class A Fund 70.82 0.52
6 Tongtai Great Health Theme Hybrid Securities Investment Fund Class A Fund 4.06 0.03
7 Jinxin Value Select Flexible Allocation Hybrid Fund Class A Fund 1.10 0.01

5. Concept Sectors

  • West Coast of the Taiwan Strait
  • Gene Concept
  • Generic Drugs
  • Assisted Reproduction
  • Hepatitis Concept
  • Innovative Drugs
  • High Price-to-Book Ratio
  • Loss-Making Stocks
  • Consecutive Losses
  • Equity Transfer
  • Increasing Shareholder Count
  • ChiNext 300
  • ChiNext Pharmaceuticals
  • ChiNext Small Cap

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information